References
1. Abadja, F., B. Sarraj, and M.J. Ansari, Significance of T helper 17 immunity in transplantation. Curr Opin Organ Transplant, 2012.17 (1): p. 8-14.
2. De Meester, I., et al., CD26, let it cut or cut it down.Immunol Today, 1999. 20 (8): p. 367-75.
3. von Bonin, A., J. Huhn, and B. Fleischer, Dipeptidyl-peptidase IV/CD26 on T cells: analysis of an alternative T-cell activation pathway. Immunol Rev, 1998. 161 : p. 43-53.
4. Ohnuma, K., N.H. Dang, and C. Morimoto, Revisiting an old acquaintance: CD26 and its molecular mechanisms in T cell function.Trends Immunol, 2008. 29 (6): p. 295-301.
5. Willheim, M., et al., Cell surface characterization of T lymphocytes and allergen-specific T cell clones: correlation of CD26 expression with T(H1) subsets. J Allergy Clin Immunol, 1997. 100 (3): p. 348-55.
6. Fan, H., et al., Dipeptidyl peptidase IV/CD26 in T cell activation, cytokine secretion and immunoglobulin production. Adv Exp Med Biol, 2003. 524 : p. 165-74.
7. Boonacker, E.P., et al., CD26/DPPIV signal transduction function, but not proteolytic activity, is directly related to its expression level on human Th1 and Th2 cell lines as detected with living cell cytochemistry.J Histochem Cytochem, 2002. 50 (9): p. 1169-77.
8. Reinhold, D., et al., The effect of anti-CD26 antibodies on DNA synthesis and cytokine production (IL-2, IL-10 and IFN-gamma) depends on enzymatic activity of DP IV/CD26. Adv Exp Med Biol, 1997.421 : p. 149-55.
9. Yan, S., et al., Enhanced ovalbumin-induced airway inflammation in CD26-/- mice. Eur J Immunol, 2012. 42 (2): p. 533-40.
10. Yan, S., et al., Deficiency of CD26 results in a change of cytokine and immunoglobulin secretion after stimulation by pokeweed mitogen.Eur J Immunol, 2003. 33 (6): p. 1519-27.
11. Steinman, L., A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med, 2007. 13 (2): p. 139-45.
12. Wilson, N.J., et al., Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol, 2007.8 (9): p. 950-7.
13. Zheng, Y., et al., Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature, 2007.445 (7128): p. 648-51.
14. Acosta-Rodriguez, E.V., et al., Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells.Nat Immunol, 2007. 8 (6): p. 639-46.
15. Bengsch, B., et al., Human Th17 cells express high levels of enzymatically active dipeptidylpeptidase IV (CD26). J Immunol,2012. 188 (11): p. 5438-47.
16. Fontenot, J.D., M.A. Gavin, and A.Y. Rudensky, Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol, 2003. 4 (4): p. 330-6.
17. Zhao, X., et al., Delayed allogeneic skin graft rejection in CD26-deficient mice. Cell Mol Immunol, 2019. 16 (6): p. 557-567.
18. Ohnuma, K., et al., Role of CD26/dipeptidyl peptidase IV in human T cell activation and function. Front Biosci, 2008. 13 : p. 2299-310.
19. Fan, H., et al., Molecular mechanism and structural basis of interactions of dipeptidyl peptidase IV with adenosine deaminase and human immunodeficiency virus type-1 transcription transactivator.Eur J Cell Biol, 2012. 91 (4): p. 265-73.
20. Schwinzer, R., et al., Monoclonal antibodies directed to different epitopes in the CD3-TCR complex induce different states of competence in resting human T cells. J Immunol, 1992. 148 (5): p. 1322-8.
21. Ziegler, S.F., F. Ramsdell, and M.R. Alderson, The activation antigen CD69. Stem Cells, 1994. 12 (5): p. 456-65.
22. Shipkova, M. and E. Wieland, Surface markers of lymphocyte activation and markers of cell proliferation. Clin Chim Acta,2012. 413 (17-18): p. 1338-49.
23. Mattern, T., et al., Expression of CD26 (dipeptidyl peptidase IV) on resting and activated human T-lymphocytes. Scand J Immunol, 1991.33 (6): p. 737-48.
24. Ibegbu, C.C., et al., Differential expression of CD26 on virus-specific CD8(+) T cells during active, latent and resolved infection. Immunology, 2009. 126 (3): p. 346-53.
25. Hatano, R., et al., CD26-mediated co-stimulation in human CD8(+) T cells provokes effector function via pro-inflammatory cytokine production. Immunology, 2013. 138 (2): p. 165-72.
26. Sugie, K., M.S. Jeon, and H.M. Grey, Activation of naive CD4 T cells by anti-CD3 reveals an important role for Fyn in Lck-mediated signaling.Proc Natl Acad Sci U S A, 2004. 101 (41): p. 14859-64.
27. Ohnuma, K., et al., Blockade of CD26-mediated T cell costimulation with soluble caveolin-1-Ig fusion protein induces anergy in CD4+T cells.Biochem Biophys Res Commun, 2009. 386 (2): p. 327-32.
28. Cherrier, D.E., N. Serafini, and J.P. Di Santo, Innate Lymphoid Cell Development: A T Cell Perspective. Immunity, 2018.48 (6): p. 1091-1103.
29. Romagnani, S., T-cell subsets (Th1 versus Th2). Ann Allergy Asthma Immunol, 2000. 85 (1): p. 9-18; quiz 18, 21.
30. Dang, N.H., et al., Comitogenic effect of solid-phase immobilized anti-1F7 on human CD4 T cell activation via CD3 and CD2 pathways.J Immunol, 1990. 144 (11): p. 4092-100.
31. Abbas, A.K., K.M. Murphy, and A. Sher, Functional diversity of helper T lymphocytes. Nature, 1996. 383 (6603): p. 787-93.
32. Harrington, L.E., et al., Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol, 2005. 6 (11): p. 1123-32.
33. Hemdan, N.Y., et al., Interleukin-17-producing T helper cells in autoimmunity. Autoimmun Rev, 2010. 9 (11): p. 785-92.
34. Pinheiro, M.M., et al., Sitagliptin inhibit human lymphocytes proliferation and Th1/Th17 differentiation in vitro. Eur J Pharm Sci, 2017. 100 : p. 17-24.
35. Zheng, H.L., et al., Changes in Th17 and IL-17 levels during acute rejection after mouse skin transplantation. Eur Rev Med Pharmacol Sci, 2014. 18 (18): p. 2720-86.
36. Yamada, Y., et al., CD26 costimulatory blockade improves lung allograft rejection and is associated with enhanced interleukin-10 expression. J Heart Lung Transplant, 2016. 35 (4): p. 508-17.
37. Salgado, F.J., et al., CD26: a negative selection marker for human Treg cells. Cytometry A, 2012. 81 (10): p. 843-55.
38. Ohnuma, K. et al. A novel role for CD26/dipeptidyl peptidase IV as a therapeutic target.Front Biosci (Landmark Ed) . 2018. 23 :p.1754-1779.